Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

UV-induced autofluorescence is effective for identifying different types of alopecia.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.